Category: Treatment
UK JVCI – third coronavirus booster vaccination likely needed in autumn 2021
A covid-19 booster vaccine is likely to be rolled out in the autumn to avoid another winter surge in the UK, a government adviser on vaccination has told The BMJ. More...
69yr old man in Hong Kong suffers facial paralysis following Sinovac coronavirus vaccination
Hong Kong reported its first case of a patient experiencing facial paralysis after being vaccinated for Covid-19 last week. More...
Operations should not take place until at least seven weeks after infection with SARS-CoV-2 coronavirus
Patients have a two and a half times higher risk of dying after the operation during the first six weeks after a SARS-CoV-2 detection compared to a later procedure. More...
EMA: Anaphylaxis and hypersensitivity reactions should be included in the list of possible side effects of the Astrazeneca vaccine
European Medicines Agency (EMA), the corona vaccine from the manufacturer Astra-Zeneca can cause severe allergic reactions. More...
Explosion of coronavirus related depression in France
At the end of the first French lockdown, one in seven people presented with a depressive syndrome, according to a study published Friday by the statistical service of social ministries, which highlights a greater vulnerability of women and young people. More...
Hungary: “Hospitals assess which coronavirus patient’s life to fight for”
There are already hospitals [in Hungary] where a separate team assesses the life expectancy of coronavirus patients. More...
Long-Haul coronavirus symptoms presenting as a variant of postural orthostatic tachycardia syndrome or POTS
Major clinical centres in Sweden have witnessed an inflow of patients with chronic symptoms following initial outpatient care for coronavirus infection, suggestive of postural orthostatic tachycardia syndrome. More...
In Milan, nine doctors and nurses test positive for coronavirus after the second dose of vaccine
Nine health workers have tested positive workers after receiving the second dose of the vaccine . More...
Antibody resistance of coronavirus variants B.1.351 (SA) and B.1.1.7 (UK)
“Findings on B.1.351 [South Africa variant] are more worrisome in that this variant is not only refractory to neutralization by most NTD mAbs but also by multiple individual mAbs to the receptor-binding motif on RBD, largely owing to an E484K mutation. More...
Covid symptoms, symptom clusters, and predictors for becoming a Longhauler
Roughly 32% of those reporting [long haul] symptoms at day 61+ in our study were initially asymptomatic at the time of SARS-CoV-2 testing. More...